Human epidermal growth factor receptor 2 (HER2) gene amplification, observed in 15–20% of breast cancers, is associated with aggressive tumor behavior and poorer prognosis (Jemal et al., 2011; Dj, 1987). The gene discussed is ERBB2; the disease is breast carcinoma.